
This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/O-PCE: Difference between revisions
Jump to navigation
Jump to search
>Kenan m fix broken data |
>Kenan m fix broken data |
||
Line 57: | Line 57: | ||
|OralROA_Common=[[Oral min common dose::5]] - [[Oral max common dose::15]] mg | |OralROA_Common=[[Oral min common dose::5]] - [[Oral max common dose::15]] mg | ||
|OralROA_Strong=[[Oral min strong dose::15]] - [[Oral max strong dose::25]] mg | |OralROA_Strong=[[Oral min strong dose::15]] - [[Oral max strong dose::25]] mg | ||
|OralROA_Heavy=[[Oral | |OralROA_Heavy=[[Oral heavy dose::25]] mg + | ||
|OralROA_TimelineFile= | |OralROA_TimelineFile= | ||
|OralROA_TimelineWidth= | |OralROA_TimelineWidth= | ||
Line 74: | Line 74: | ||
|InsufflatedROA_Common=[[Insufflated min common dose::6]] - [[Insufflated max common dose::12]] mg | |InsufflatedROA_Common=[[Insufflated min common dose::6]] - [[Insufflated max common dose::12]] mg | ||
|InsufflatedROA_Strong=[[Insufflated min strong dose::12]] - [[Insufflated max strong dose::20]] mg | |InsufflatedROA_Strong=[[Insufflated min strong dose::12]] - [[Insufflated max strong dose::20]] mg | ||
|InsufflatedROA_Heavy=[[Insufflated | |InsufflatedROA_Heavy=[[Insufflated heavy dose::20]] mg + | ||
|InsufflatedROA_TimelineFile= | |InsufflatedROA_TimelineFile= | ||
|InsufflatedROA_TimelineWidth= | |InsufflatedROA_TimelineWidth= |
Revision as of 00:53, 22 December 2017
SubstanceBox/O-PCE | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemical Nomenclature | |||||||||||||||||||||||||||||||||||||||||||||||||
Common names | O-PCE, Eticyclidone | ||||||||||||||||||||||||||||||||||||||||||||||||
Substitutive name | 2'-Oxo-PCE | ||||||||||||||||||||||||||||||||||||||||||||||||
Systematic name | 2-(Ethylamino)-2-phenylcyclohexan-1-one | ||||||||||||||||||||||||||||||||||||||||||||||||
Class Membership | |||||||||||||||||||||||||||||||||||||||||||||||||
Psychoactive class | Dissociative | ||||||||||||||||||||||||||||||||||||||||||||||||
Chemical class | Arylcyclohexylamine | ||||||||||||||||||||||||||||||||||||||||||||||||
Routes of Administration | |||||||||||||||||||||||||||||||||||||||||||||||||
|